Search results
20 hours ago · Cultural Ambassadors on Banknotes: Dive into how the figures selected for the new banknotes—Shibusawa Eiichi, Tsuda Umeko, and Kitasato Shibasaburō—embody the traits Japan wishes to project globally: entrepreneurial spirit, educational innovation, and scientific breakthroughs.
1 day ago · Kitasato Shibasaburō, first dean of Keio University School of Medicine; member of Japan Academy, fellow of Royal Society of London, nominated for Nobel Prize; Ryogo Kubo, the Boltzmann Medal, Order of Culture, member of Japan Academy, International Honorary Member of American Academy of Arts and Sciences
- Kohei Itoh
- 11,680
- 33,437 (As of May 1, 2022)
- Urban
1 day ago · The study of antibodies began in 1890 when Emil von Behring and Kitasato Shibasaburō described antibody activity against diphtheria and tetanus toxins. Von Behring and Kitasato put forward the theory of humoral immunity, proposing that a mediator in serum could react with a foreign antigen.
May 9, 2024 · The genus is named for French bacteriologist Alexandre Yersin, who in 1894 discovered Pasteurella pestis (now Yersinia pestis ), the causative agent of plague, which was independently isolated that same year by Japanese physician and bacteriologist Kitasato Shibasaburo.
- Kara Rogers
May 8, 2024 · Emil von Behring and Shibasaburo Kitasato working together in Berlin in 1890 announce the discovery of diphtheria antitoxin serum, the first rational approach to therapy of infectious diseases. They inject a sublethal dose of diphtheria filtrate into animals and produce a serum that is specifically capable of neutralizing the toxin.
- Karen Yee
- 2018
5 days ago · Kitasato Shibasaburō and Alexandre Yersin Paul-Louis Simond and the plague vectors: Rattus rattus (Black Rat) and Xenopsylla cheopis (Oriental Flea) Medieval manuscript illustration (14 th -century image from James le Palmer’s encyclopedia Omne Bonum ) probably showing plague pustules
Apr 24, 2024 · Abstract. Background: Endoscopic healing (EH) is a therapeutic target in ulcerative colitis (UC). However, even patients who have achieved EH relapse frequently. Aims: To investigate the association between recent steroid use and relapse risk in UC patients with EH.
